Submitted by Anonymous (not verified) on 19 December 2023 - 13:00
Stakeholder workshop on support to quality development in early access approaches, such as PRIME and Breakthrough Therapies, European Medicines Agency, Amsterdam, the Netherlands, 26 November 2018
Source: